Literature DB >> 3715951

Effect of nimodipine on cerebral functional and metabolic recovery following ischemia in the rat brain.

H Mabe, H Nagai, T Takagi, S Umemura, M Ohno.   

Abstract

Whether the calcium entry blocker, nimodipine, prevents the increase in the concentration of free fatty acids and metabolic disturbances during ischemia and promotes functional and metabolic recovery after recirculation were examined. Severe forebrain ischemia in rats was induced by four-vessel occlusion with mild hypotension. After 30 minutes of ischemia, recirculation was started by removal of the arterial clamps and by increasing blood pressure to the preischemic level. Recovery of EEG activity following recirculation was better in the nimodipine-treated group than in the control group. During the ischemic period, there were no significant differences in accumulation of free fatty acids or in depletion of ATP between treated and control groups. At 120 minutes following recirculation, recovery of the ATP level was significantly better in the treated group than in the control group. Therefore, the promotion of functional and metabolic recovery by nimodipine-treatment is suggested to be not due to the prevention of an accumulation of free fatty acids nor to the depletion of ATP during the ischemic period, but to either improvement of postischemic hypoperfusion or a direct action on metabolic processes during reperfusion period.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3715951     DOI: 10.1161/01.str.17.3.501

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  8 in total

1.  Effect of nicardipine on somatosensory evoked potentials in patients with acute cerebral infarction.

Authors:  L P Yao; D Y Ding
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-10       Impact factor: 10.154

2.  Neurology: neurologic use of calcium channel blocking agents.

Authors:  J F Rothrock
Journal:  West J Med       Date:  1987-03

3.  Nimodipine has no beneficial effect on neurological outcome in a cardiopulmonary arrest model in the rat.

Authors:  P A Calle; M G Bogaert; L De Ridder; W A Buylaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-06       Impact factor: 3.000

4.  Comparison of the calcium entry blockers nimodipine and flunarizine on human cerebral and temporal arteries: role in cerebrovascular disorders.

Authors:  I Jansen; P Tfelt-Hansen; L Edvinsson
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 5.  Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease.

Authors:  M S Langley; E M Sorkin
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

6.  Effects of NG-nitro-L-arginine and L-arginine on regional cerebral blood flow in the cat.

Authors:  A G Kovách; C Szabó; Z Benyó; C Csáki; J H Greenberg; M Reivich
Journal:  J Physiol       Date:  1992-04       Impact factor: 5.182

7.  Cyclandelate versus flunarizine. A double-blind study in a selected group of patients with dementia.

Authors:  M G Albizzati; S Bassi; E Calloni; M Sbacchi; R Piolti; L Frattola
Journal:  Drugs       Date:  1987       Impact factor: 9.546

8.  A trial of the effect of nimodipine on outcome after head injury.

Authors:  I Bailey; A Bell; J Gray; R Gullan; O Heiskanan; P V Marks; H Marsh; D A Mendelow; G Murray; J Ohman
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.